Metraipolis › archive › dc_4cffd32ee434
QT-related adverse events with ondansetron and olanzapine: a real-world FAERS analysis with implications for oncology anti-emetic practice — Europe PMC PMID:41800097
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41800097
- DOI
- 10.3389/fphar.2026.1748635
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T14:10:13.315Z
- SHA-256 of the archived text
695c5b5c6a91f9229a4747e815ade5239808f740da2efe098f4d380edbf86a5e- Stable URL of this page
https://metraipolis.com/documento/dc_4cffd32ee434
How to cite
QT-related adverse events with ondansetron and olanzapine: a real-world FAERS analysis with implications for oncology anti-emetic practice — Europe PMC PMID:41800097 — Europe PMC (en), https://europepmc.org/article/MED/41800097 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4cffd32ee434 (Metraipolis archive dc_4cffd32ee434, sha256 695c5b5c6a91f9229a4747e815ade5239808f740da2efe098f4d380edbf86a5e)
BibTeX
@misc{dc4cffd32ee434,
title = {QT-related adverse events with ondansetron and olanzapine: a real-world FAERS analysis with implications for oncology anti-emetic practice — Europe PMC PMID:41800097},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41800097},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4cffd32ee434; sha256 695c5b5c6a91f9229a4747e815ade5239808f740da2efe098f4d380edbf86a5e},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41800097. Agents can read the archived copy with the MCP tool read_document.